Click to copy

Press release content from Business Wire. The AP news staff was not involved in its creation.

Click to copy

Global Nucleic Acid Testing/NAT Market, 2019-2023: Emerging Opportunities in US, Europe, Japan-Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts - ResearchAndMarkets.com

October 11, 2019

DUBLIN--(BUSINESS WIRE)--Oct 11, 2019--

The “Global Nucleic Acid Testing/NAT Market, 2019-2023: Emerging Opportunities in US, Europe, Japan-Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts-Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing” report has been added to ResearchAndMarkets.com’s offering.

This new seven-country study from the author contains 1,398 pages, 194 tables, and is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the molecular diagnostics market during the next five years.

Highlights

Rationale

The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods.

In order to successfully capitalize on the opportunities presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years.

Geographic Coverage

Worldwide Market Overview

Market Segmentation Analysis

Product/Technology Review

Competitive Assessments

Opportunities and Strategic Recommendations

Companies Mentioned

For more information about this report visit https://www.researchandmarkets.com/r/k2y557

View source version on businesswire.com:https://www.businesswire.com/news/home/20191011005262/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: HEALTH MEDICAL DEVICES RESEARCH SCIENCE BIOTECHNOLOGY

SOURCE: Research and Markets

PUB: 10/11/2019 08:09 AM/DISC: 10/11/2019 08:08 AM

http://www.businesswire.com/news/home/20191011005262/en